Johannes Schmoellerl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.
Journal: Science translational medicine
Published: November 26, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12.
Journal: Nature communications
Published: March 06, 2024
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.
Journal: Nature communications
Published: March 19, 2023
SBNO2 is a critical mediator of STAT3-driven hematological malignancies.
Journal: Blood
Published: September 20, 2022
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.
Journal: Nature communications
Published: March 07, 2022
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.
Journal: Cancers
Published: July 23, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Journal: Leukemia
Published: July 16, 2020
Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Journal: Nature structural & molecular biology
Published: November 07, 2019
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Journal: Blood
Published: September 10, 2019
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Journal: Leukemia
Published: February 25, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.
Journal: Nature communications
Published: October 31, 2017
Last Updated: 09/26/2026